YN320931 Azilsartan 147403-03-0

Azilsartan is an angiotensin II type 1 (AT1) receptor antagonist with IC50 of 2.6 nM.

YN321210 Elisartan 149968-26-3

Elisartan is an orally active non-peptide pro-drug ofangiotensin II AT1 receptorantagonist HN-12206, and shows anti-hypertension activities.

YN320152 Pratosartan 153804-05-8

Pratosartan is a selectiveangiotensin II receptorantagonist.

YN322052 L162441 154512-46-6

L162441 is anAngiotensin type 1 receptorantagonist.

YN320730 Olmesartan impurity 154709-18-9

Olmesartan impurity is an Olmesartan impurity. Olmesartan (RNH-6270) is anangiotensin II receptor (AT1R)antagonist has the potential for high blood pressure study.

YN321208 L-159282 157263-00-8

L-159282 is a highly potent, orally active, nonpeptideangiotensin II receptorantagonist, with anti-hypertensive activity.

YN321812 A 779 159432-28-7

A 779 is a specific antagonist of G-protein coupled receptor (Mas receptor), which is anAng1-7 receptordistinct from the classical AngII.

YN322041 LY285434 159748-08-0

LY285434 is a suitableangiotensin II receptorantagonist.

YN320162 L162389 169281-53-2

L162389 is a potent antagonist ofangiotensin AT1 receptor with Kiof 28nM.

YN320698 Dehydro Olmesartan 172875-98-8

Dehydro Olmesartan is a derivative of Olmesartan. Olmesartan is anangiotensin II receptor (AT1R)antagonist and has the potential for high blood pressure study.

YN321577 Fimasartan 247257-48-3

Fimasartan is a non-peptide angiotensin II receptor antagonist (ARB) with noncompetitive, insurmountable binding with the AT1 receptor. It is used for the treatment of hypertension and heart failure.

YN321170 Sparsentan 254740-64-2

Sparsentan is a dual endothelin type A receptor(ETA) and angiotensin II type 1 receptor antagonist.

YN321032 AVE 0991 304462-19-9

AVE 0991 is a nonpeptide and orally activeangiotensin-(1-7) receptoragonist with an IC50 of 21nM.

YN321033 AVE 0991 sodium salt 306288-04-0

AVE 0991 sodium salt is a nonpeptide and orally activeAng-(1-7) receptor Masagonist. AVE 0991 competes for high-affinity binding of [125I]-Ang-(1-7) to bovine aortic endothelial cell membranes with IC50 of 21nM.

YN320004 AT2 receptor agonist C21 477775-14-7

AT2 receptor agonist C21 is a druglike selectiveangiotensin II AT2 receptoragonist with Ki values of 0.4nM and >10µM for the AT2 receptor and AT1 receptor, respectively.

YN320697 Olmesartan lactone impurity 849206-43-5

Olmesartan lactone impurity is a cyclic ester impurity of Olmesartan. Olmesartan is anangiotensin II receptor (AT1R)antagonist and has the potential for high blood pressure study.

YN320903 Azilsartan medoxomil 863031-21-4

Azilsartan Medoxomil is a potent angiotensin II type 1 (AT1) receptor antagonist, inhibits the RAAS, with an IC50 of 2.6 nM, exhibits >10,000-fold selectivity over AT2.

YN320696 Olmesartan medoxomil impurity... 879562-26-2

Olmesartan medoxomil impurity C is an Olmesartan medoxomil impurity. Olmesartan medoxomil is a potent and selectiveangiotensin AT1 receptorinhibitor with IC50 of 66.2μM.

YN321181 LCZ696 936623-90-4

LCZ696 (Sacubitril/Valsartan), comprised Valsartan (an ARB) and Sacubitril (AHU377) in 1:1 molar ratio, is a first-in-class, orally bioavailable, and dual-actingangiotensin receptor-neprilysin (ARN)inhibitor for hyperten...

YN321158 Losartan D4 1030937-27-9

Losartan D4 (DuP-753 D4) is the deuterium labeled Losartan. Losartan is anangiotensin II receptorantagonist, competing with the binding of angiotensin II to AT1 receptors with IC50 of 20nM.